APOGEPHA Arzneimittel

APOGEPHA is an independent, family-owned German pharmaceutical company that specializes in the field of urology. Founded in 1882 and headquartered in Dresden, the company focuses on the development, production, and distribution of innovative treatments for urological conditions. Its core portfolio includes therapies for overactive bladder, urinary incontinence, and benign prostatic hyperplasia, with its flagship product Mictonorm (propiverine) being a market leader in several regions. APOGEPHA maintains a strong international presence through a network of distribution partners and licensees across more than 25 countries. The company combines a long-standing tradition in pharmaceutical manufacturing with modern research to address unmet needs in urological health.